Quick Listen: The Story Behind The Pharmaprojects’ Pharma R&D Annual Review 2021
Executive Summary
In this one-off podcast, hear in the inside story of how the Pharmaprojects’ Pharma R&D Annual Review 2021 is put together, its history and the trends it has revealed in R&D over the years.
You may also be interested in...
The 2021 Worldwide Pharma And Biotech R&D Scene
INFOGRAPHIC: A snapshot of the industry in key performance indicators surrounding R&D taken in early 2021.
COVID-19 Made Its Mark On the R&D Pipeline And Novel Drug Launches In 2020
A new analysis reveals the impact of the coronavirus pandemic on pharma R&D in 2020 in two quarters: the total size of the pipeline and in the number of novel products launched in their first markets.
Worldwide Novel Drug Launches Soared Amid Pandemic
The number of novel products launched in their first markets in 2020 hit record heights in spite of – and in part buoyed by – the pandemic, with an exceptional year for infectious diseases therapeutics and vaccines.